These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 25464252)

  • 1. Ischemic cardiovascular involvement in psoriasis: a systematic review.
    Mosca S; Gargiulo P; Balato N; Di Costanzo L; Parente A; Paolillo S; Ayala F; Trimarco B; Crea F; Perrone-Filardi P
    Int J Cardiol; 2015 Jan; 178():191-9. PubMed ID: 25464252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular Involvement in Psoriasis, Diagnosing Subclinical Atherosclerosis, Effects of Biological and Non-Biological Therapy: A Literature Review.
    Valaiyaduppu Subas S; Mishra V; Busa V; Antony I; Marudhai S; Patel M; Cancarevic I
    Cureus; 2020 Oct; 12(10):e11173. PubMed ID: 33262910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Risk in Psoriasis: Current State of the Art.
    Dattilo G; Borgia F; Guarneri C; Casale M; Bitto R; Morabito C; Signorelli S; Katsiki N; Cannavò SP
    Curr Vasc Pharmacol; 2019; 17(1):85-91. PubMed ID: 29149819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel anti-inflammatory therapies to reduce cardiovascular burden of psoriasis.
    Piros ÉA; Szilveszter B; Vattay B; Maurovich-Horvat P; Szalai K; Dósa E; Merkely B; Holló P
    Dermatol Ther; 2021 Jan; 34(1):e14721. PubMed ID: 33373079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of cardiovascular disease in patients with psoriasis.
    Egeberg A; Skov L
    Expert Opin Pharmacother; 2016 Aug; 17(11):1509-16. PubMed ID: 27192114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating the Link between Psoriasis and Cardiovascular Disease: Current Evidence, Therapeutic Implications and Perspectives.
    Kapniari E; Papadimitriou P; Dalamaga M; Makavos G; Piaserico S; Egeberg A; Ikonomidis I; Papadavid E
    Curr Vasc Pharmacol; 2020; 18(6):592-609. PubMed ID: 32445456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic Disorders in Psoriatic Disease.
    Sobchak C; Eder L
    Curr Rheumatol Rep; 2017 Aug; 19(10):63. PubMed ID: 28844116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular aspects of psoriasis: an updated review.
    Pietrzak A; Bartosińska J; Chodorowska G; Szepietowski JC; Paluszkiewicz P; Schwartz RA
    Int J Dermatol; 2013 Feb; 52(2):153-62. PubMed ID: 23347301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis.
    Joshi AA; Lerman JB; Aberra TM; Afshar M; Teague HL; Rodante JA; Krishnamoorthy P; Ng Q; Aridi TZ; Salahuddin T; Natarajan B; Lockshin BN; Ahlman MA; Chen MY; Rader DJ; Reilly MP; Remaley AT; Bluemke DA; Playford MP; Gelfand JM; Mehta NN
    Circ Res; 2016 Nov; 119(11):1242-1253. PubMed ID: 27654120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
    Radner H; Lesperance T; Accortt NA; Solomon DH
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and cardiovascular disorders.
    Frieder J; Ryan C
    G Ital Dermatol Venereol; 2016 Dec; 151(6):678-693. PubMed ID: 27627099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Diagnostic, and Therapeutic Implications in Psoriasis Associated With Cardiovascular Disease.
    Bonanad C; González-Parra E; Rivera R; Carrascosa JM; Daudén E; Olveira A; Botella-Estrada R
    Actas Dermosifiliogr; 2017 Nov; 108(9):800-808. PubMed ID: 28610662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The concept of psoriasis as a systemic inflammation: implications for disease management.
    Reich K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.
    Yim KM; Armstrong AW
    Rheumatol Int; 2017 Jan; 37(1):97-105. PubMed ID: 27221457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the risk of cardiovascular disease in patients with psoriasis: a critical review.
    Papp K; Poulin Y; Vieira A
    J Cutan Med Surg; 2013; 17(2):89-105. PubMed ID: 23582163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.